Successfully Design & Develop Next-Generation of mRNA- Based Vaccines & Therapeutics with Improved Specificity, Delivery & Efficacy for Immuno-Oncology, Infectious Diseases & Beyond The dramatic success of mRNA- based vaccines has marked the beginning of what looks to be a limitless opportunity for mRNA- based therapeutics to disrupt the biopharma
25-27 January 2022